Key result
Decongestive therapy with diuretics or ultrafiltration decreases volume overload and improves symptoms in cardiorenal syndrome, but its impact on kidney function or mortality remains uncertain.
Why the study?
Venous congestion plays an important role in combined cardiac and renal disease, prompting a review focused on its pathophysiology in heart failure and the use of diuretics or ultrafiltration for decongestion in CRS.
Does decongestive therapy with diuretics or ultrafiltration improve kidney function or mortality in patients with cardiorenal syndrome?
Does decongestive therapy with diuretics or ultrafiltration improve kidney function or mortality in patients with cardiorenal syndrome?
While diuretics and ultrafiltration effectively reduce volume overload and symptoms in cardiorenal syndrome, their impact on renal function and mortality remains uncertain, emphasizing the need for objective measures of venous congestion.
No takes yet. Share an insight, caveat, or question.
May relieve symptoms in cardiorenal syndrome but leaves renal and mortality effects uncertain; prospective trials needed before practice change.
Lim et al. (2021) conducted a review in Cardiorenal syndrome. Diuretics and Ultrafiltration was evaluated. Decongestive therapy with diuretics or ultrafiltration decreases volume overload and improves symptoms in cardiorenal syndrome, but its impact on kidney function or mortality remains uncertain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: